Neuroone Medical Technologies Corp Announces Successful Robotic-Assisted Drug Delivery Using Stereoced Platform
N
NMTC• Company announces successful robotic-assisted drug delivery
Aug. 27 (Reuters) - Neuroone Medical Technologies Corp (NMTC.O):
- Neuroone Medical Technologies Corp announces successful robotic-assisted drug delivery using Stereoced platform - SEC filing
- Neuroone Medical Technologies Corp plans launch of Stereoced platform for human investigational clinical studies later this quarter - SEC filing
- Stereoced revenue expected to be recognized in current fiscal quarter - SEC filing
Source text: [ID:n0001213900-26-094174]
Further company coverage: NMTC.O
PGR
•
Neuroone Medical Technologies Corp Announces Successful Robotic-Assisted Drug Delivery Using Stereoced Platform - NMTC News | Rallies
